Top Suppliers:I want be here


1353550-13-6

1353550-13-6 structure
1353550-13-6 structure
  • Name: Olmutinib
  • Chemical Name: N-[3-[[2-[[4-(4-Methyl-1-piperazinyl)phenyl]amino]thieno[3,2-d]pyrimidin-4-yl]oxy]phenyl]-2-propenamide
  • CAS Number: 1353550-13-6
  • Molecular Formula: C26H26N6O2S
  • Molecular Weight: 486.589
  • Catalog: Research Areas Cancer
  • Create Date: 2018-09-05 22:21:02
  • Modify Date: 2024-01-07 19:50:31
  • Olmutinib (HM61713; BI-1482694) is an irreversible EGFR tyrosine kinase inhibitor that binds to a cysteine residue near the kinase domain.

Name N-[3-[[2-[[4-(4-Methyl-1-piperazinyl)phenyl]amino]thieno[3,2-d]pyrimidin-4-yl]oxy]phenyl]-2-propenamide
Synonyms N-{3-[(2-{[4-(4-Methyl-1-piperazinyl)phenyl]amino}thieno[3,2-d]pyrimidin-4-yl)oxy]phenyl}acrylamide
2-Propenamide, N-[3-[[2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]thieno[3,2-d]pyrimidin-4-yl]oxy]phenyl]-
Olmutinib
N-(3-(2-(4-(4-methylpiperazin-1-yl)phenylamino) thieno[3,2-d]pyrimidin-4-yloxy)phenyl)acrylamide
HM71224
Description Olmutinib (HM61713; BI-1482694) is an irreversible EGFR tyrosine kinase inhibitor that binds to a cysteine residue near the kinase domain.
Related Catalog
Target

EGFRExon 19 deletion:9.2 nM (IC50, Cell Assay)

EGFRL858R/T790M:10 nM (IC50, Cell Assay)

In Vitro Olmutinib potently inhibits EGFR in HCC827 cells expressing EGFRDEL19 (IC50=9.2 nM) and H1975 cells expressing EGFRL858R/T790M (IC50=10 nM). In contrast, the IC50 of olmutinib against cells expressing EGFRWT is 2225 nM[1].
References

[1]. Kim ES, et al. Olmutinib: First Global Approval. Drugs.?2016 Jul;76(11):1153-7.

Density 1.3±0.1 g/cm3
Molecular Formula C26H26N6O2S
Molecular Weight 486.589
Exact Mass 486.183807
PSA 110.86000
LogP 4.95
Index of Refraction 1.706
Storage condition -20℃